Search Results - Alfred Zippelius

Refine Results
  1. 1

    Tertiary Lymphoid Structures as a Predictive Biomarker of Response to Cancer Immunotherapies by Marta Trüb, Alfred Zippelius, Alfred Zippelius

    Published in Frontiers in Immunology (2021-05-01)
    Get full text
    Article


  2. 2

    Antibody-Drug Conjugates in Solid Tumors by Ilaria Colombo, Alfred Zippelius

    Published in healthbook TIMES. Oncology Hematology (2022-03-01)
    Get full text
    Article


  3. 3

    Pembrolizumab-induced optic neuropathy – a case report by Eveline Daetwyler, Alfred Zippelius, Alfred Zippelius, Peter Meyer, Heinz Läubli, Heinz Läubli

    Published in Frontiers in Immunology (2023-05-01)
    Get full text
    Article


  4. 4

    Nivolumab-induced diabetes mellitus—a case report with literature review of the treatment options by Eveline Daetwyler, Alfred Zippelius, Alfred Zippelius, Simona Danioth, Marc Y. Donath, Marc Y. Donath, Lara Gut, Lara Gut

    Published in Frontiers in Immunology (2023-10-01)
    Get full text
    Article


  5. 5

    Tumor-associated carbohydrates and immunomodulatory lectins as targets for cancer immunotherapy by Alfred Zippelius, Heinz Läubli, Natalia Rodrigues Mantuano, Marina Natoli

    Published in Journal for ImmunoTherapy of Cancer (2020-10-01)
    Get full text
    Article


  6. 6

    Changes of peripheral T cell subsets in melanoma patients with immune-related adverse events by Benjamin Müller, Anne Bärenwaldt, Petra Herzig, Alfred Zippelius, Alfred Zippelius, Lara Valeska Maul, Viviane Hess, David König, David König, Heinz Läubli, Heinz Läubli

    Published in Frontiers in Immunology (2023-04-01)
    Get full text
    Article


  7. 7

    Treatment of mycophenolate-resistant immune-related organizing pneumonia with infliximab by Guacimara Ortega Sanchez, Kathleen Jahn, Spasenija Savic, Alfred Zippelius, Heinz Läubli

    Published in Journal for ImmunoTherapy of Cancer (2018-09-01)
    Get full text
    Article


  8. 8

    Cancer immunology – development of novel anti-cancer therapies by Sacha I Rothschild, Daniela S Thommen, Wolfgang Moersig, Philipp Müller, Alfred Zippelius

    Published in Swiss Medical Weekly (2015-01-01)
    Get full text
    Article


  9. 9

    Corticosteroid-resistant immune-related adverse events: a systematic review by Laura C Cappelli, Jarushka Naidoo, Alfred Zippelius, Heinz Läubli, David König, Eveline Daetwyler, Till Wallrabenstein

    Published in Journal for ImmunoTherapy of Cancer (2024-01-01)
    Get full text
    Article


  10. 10

    Protocol for ex vivo culture of patient-derived tumor fragments by Lisanne M. Roelofsen, Paula Voabil, Marjolein de Bruijn, Petra Herzig, Alfred Zippelius, Ton N. Schumacher, Daniela S. Thommen

    Published in STAR Protocols (2023-06-01)
    Get full text
    Article


  11. 11

    Toxicity associated with PD-1 blockade after allogeneic haematopoietic cell transplantation by Guacimara Ortega Sanchez, Frank Stenner, Stefan Dirnhofer, Jakob Passweg, Sabine Gerull, Jörg P. Halter, Alfred Zippelius, Heinz Läubli

    Published in Swiss Medical Weekly (2019-11-01)
    Get full text
    Article


  12. 12

    Immunotherapy in head and neck cancer – scientific rationale, current treatment options and future directions by Uta Rothschild, Laurent Muller, Axel Lechner, Hans A. Schlöẞer, Dirk Beutner, Heinz Läubli, Alfred Zippelius, Sacha I. Rothschild

    Published in Swiss Medical Weekly (2018-05-01)
    Get full text
    Article


  13. 13

    933 Heme-mediated reprogramming guides CD8+ T cell exhaustion in response to mitochondrial dysfunction by Alfred Zippelius, Ping-Chih Ho, Rahul Roychoudhuri, Zhengtao Xiao, Yu-Ming Chuang, Yingxi Xu, Jhan-Jie Peng, Maryam Akrami

    Published in Journal for ImmunoTherapy of Cancer (2023-11-01)
    Article


  14. 14

    Exacerbation of demyelinating polyneuropathy after adoptive cell therapy with tumour-infiltrating lymphocytes by metastatic melanoma by Elisa Canini, Lorenza Pacchin, Ann Kristine Blackham, Johannes Lorscheider, Jakob Passweg, Alfred Zippelius, Heinz Läubli, Markus R. Mutke, David König

    Published in Swiss Medical Weekly (2025-08-01)
    Get full text
    Article


  15. 15

    Pre‐treatment comorbidities, C‐reactive protein and eosinophil count, and immune‐related adverse events as predictors of survival with checkpoint inhibition for multiple tumour ent... by Tarun Mehra, Kanchan Dongre, Maria Boesing, Patricia Frei, Claudia Suenderhauf, Alfred Zippelius, Joerg D. Leuppi, Andreas Wicki, Anne B. Leuppi‐Taegtmeyer

    Published in Cancer Medicine (2023-06-01)
    Get full text
    Article


  16. 16

    Grover’s-like drug eruption in a patient with metastatic melanoma under ipilimumab therapy by Alfred Zippelius, Viktor H. Koelzer, Sacha I. Rothschild, Andreas Wicki, Niels Willi, Gieri Cathomas, Kirsten D. Mertz, Tobias Buser, Peter Schiller

    Published in Journal for ImmunoTherapy of Cancer (2016-06-01)
    Get full text
    Article


  17. 17

    The T cell repertoire in tumors overlaps with pulmonary inflammatory lesions in patients treated with checkpoint inhibitors by Heinz Läubli, Viktor H. Koelzer, Matthias S. Matter, Petra Herzig, Béatrice Dolder Schlienger, Mark Nikolaj Wiese, Didier Lardinois, Kirsten D. Mertz, Alfred Zippelius

    Published in OncoImmunology (2018-02-01)
    Get full text
    Article


  18. 18

    881 Knockdown of neuropilin-1 by third generation antisense oligonucleotides has strong antitumor activity that can be further increased by combination with immune checkpoint inhib... by Alfred Zippelius, Mélanie Buchi, Richard Klar, Julia Festag, Monika Schell, Sven Michel, Frank Jaschinski, Nicole Kirchhammer, Andre Maaske, Laura Fernandez Rodriguez, Stefanie Raith

    Published in Journal for ImmunoTherapy of Cancer (2023-11-01)
    Article


  19. 19

    Clinical and pathological factors and outcome of central nervous system metastasis in breast cancer by Dimitri Dettwiler, Elena-Diana Chiru, Eveline Daetwyler, Vérène Dougoud-Chauvin, Markus W. Gross, Christian Kurzeder, Alfred Zippelius, Andreas Schötzau, Marcus Vetter, Marcus Vetter, Marcus Vetter, Marcus Vetter

    Published in Frontiers in Oncology (2023-09-01)
    Get full text
    Article


  20. 20

    13C tracer analysis reveals the landscape of metabolic checkpoints in human CD8+ T cell differentiation and exhaustion by Alexander Kirchmair, Niloofar Nemati, Giorgia Lamberti, Marcel Trefny, Anne Krogsdam, Anne Krogsdam, Anita Siller, Paul Hörtnagl, Petra Schumacher, Sieghart Sopper, Adolf Sandbichler, Alfred Zippelius, Bart Ghesquière, Bart Ghesquière, Zlatko Trajanoski

    Published in Frontiers in Immunology (2023-10-01)
    Get full text
    Article


Search Tools: